DR REDDYS LABORATORIES Financial Statement Analysis
|
||
The Revenues of DR REDDYS LABORATORIES have increased by 13.54% YoY .
The Earnings Per Share (EPS) of DR REDDYS LABORATORIES has decreased by -79.72 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
DR REDDYS LABORATORIES Last 5 Annual Financial Results
[BOM: 500124|NSE : DRREDDY]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Revenues | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr |
Expenses | ₹20,078 Cr | ₹18,321 Cr | ₹17,778 Cr | ₹15,178 Cr | ₹15,047 Cr |
Operating Profit (Excl OI) | ₹7,933 Cr | ₹6,349 Cr | ₹3,767 Cr | ₹3,870 Cr | ₹2,470 Cr |
Other Income | ₹894 Cr | ₹1,056 Cr | ₹485 Cr | ₹291 Cr | ₹621 Cr |
Interest | ₹171 Cr | ₹143 Cr | ₹96 Cr | ₹97 Cr | ₹98 Cr |
Depreciation | ₹1,470 Cr | ₹1,250 Cr | ₹1,165 Cr | ₹1,229 Cr | ₹1,163 Cr |
Profit Before Tax | ₹7,201 Cr | ₹6,049 Cr | ₹3,061 Cr | ₹2,884 Cr | ₹1,886 Cr |
Profit After Tax | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr |
Consolidated Net Profit | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr |
Earnings Per Share (Rs) | ₹67.81 | ₹334.41 | ₹270.55 | ₹131.16 | ₹117.28 |
PAT Margin (%) | 17.54 | 19.91 | 18.27 | 10.13 | 10.25 |
ROE(%) | 18.61 | 21.76 | 21.36 | 11.93 | 11.82 |
ROCE(%) | 23.25 | 26.86 | 26.22 | 14.59 | 15.49 |
Total Debt/Equity(x) | 0.14 | 0.07 | 0.06 | 0.18 | 0.17 |
Key Financials |
||
Market Cap | : | ₹ 105,255.6 Cr |
Revenue (TTM) | : | ₹ 32,643.9 Cr |
Net Profit(TTM) | : | ₹ 5,703.5 Cr |
EPS (TTM) | : | ₹ 68.3 |
P/E (TTM) | : | 18.5 |
Industry Peers & Returns | 1W | 1M | 1Y |
DR REDDYS LABORATORIES | -0.7% | -6.4% | -5.2% |
SUN PHARMACEUTICAL INDUSTRIES | 3.6% | 2.5% | 6.2% |
DIVIS LABORATORIES | -2.9% | 1.5% | 48.1% |
CIPLA | -0.1% | -2.4% | -1.4% |
TORRENT PHARMACEUTICALS | 2.5% | 4.9% | 15.2% |
MANKIND PHARMA | 5% | 12% | 27.4% |
ZYDUS LIFESCIENCES | -1.1% | -0.7% | -16.8% |
LUPIN | 2% | -2.9% | 5.9% |
AUROBINDO PHARMA | 0.7% | 0.7% | -13.6% |
DR REDDYS LABORATORIES Revenues
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | 13.54 % |
5 Yr CAGR | 12.45 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹28,011 Cr | 13.54 | |
Mar2024 | ₹24,670 Cr | 14.50 | |
Mar2023 | ₹21,545 Cr | 13.11 | |
Mar2022 | ₹19,048 Cr | 8.74 | |
Mar2021 | ₹17,517 Cr | - |
DR REDDYS LABORATORIES Operating Profit
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | 24.95 % |
5 Yr CAGR | 33.87 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹7,933 Cr | 24.95 | |
Mar2024 | ₹6,349 Cr | 68.52 | |
Mar2023 | ₹3,767 Cr | -2.65 | |
Mar2022 | ₹3,870 Cr | 56.65 | |
Mar2021 | ₹2,470 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 10.02 % |
5 Yr CAGR | 19.05 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 28.32% | 10.02 | |
Mar2024 | 25.74% | 47.17 | |
Mar2023 | 17.49% | -13.93 | |
Mar2022 | 20.32% | 44.11 | |
Mar2021 | 14.1% | - |
DR REDDYS LABORATORIES Profit After Tax
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | 23.75 % |
5 Yr CAGR | 28.81 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹5,578 Cr | 23.75 | |
Mar2024 | ₹4,507 Cr | 106.52 | |
Mar2023 | ₹2,183 Cr | 11.83 | |
Mar2022 | ₹1,952 Cr | -3.67 | |
Mar2021 | ₹2,026 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -11.90 % |
5 Yr CAGR | 14.37 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 17.54 % | -11.90 | |
Mar2024 | 19.91 % | 8.98 | |
Mar2023 | 18.27 % | 80.36 | |
Mar2022 | 10.13 % | -1.17 | |
Mar2021 | 10.25 % | - |
DR REDDYS LABORATORIES Earnings Per Share (EPS)
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | -79.72 % |
5 Yr CAGR | -12.80 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹68 | -79.72 | |
Mar2024 | ₹334 | 23.60 | |
Mar2023 | ₹271 | 106.27 | |
Mar2022 | ₹131 | 11.83 | |
Mar2021 | ₹117 | - |
DR REDDYS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | -13.44 % |
5 Yr CAGR | 10.69 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 23.25% | -13.44 | |
Mar2024 | 26.86% | 2.44 | |
Mar2023 | 26.22% | 79.71 | |
Mar2022 | 14.59% | -5.81 | |
Mar2021 | 15.49% | - |
DR REDDYS LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹1,261.2 |
Current MarketCap | : | ₹ 105,255.6 Cr |
Updated EOD on | : | Jul 15,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -0.7% |
-6.4% |
-5.2% |
SENSEX | -1.4% |
1.8% |
3.3% |
DR REDDYS LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE LARGEMIDCAP | 4.5% | 7.2% | 8.3% |
BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
BSE HEALTHCARE | 1.9% | 3.1% | 17.6% |
BSE 200 EQUAL WEIGHT | -0.2% | 1.9% | NA |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY PHARMA | 2.3% | 3.1% | 9.4% |
NIFTY HEALTHCARE INDEX | 1.4% | 3.2% | 12.6% |
NIFTY 500 EQUAL WEIGHT | 0.8% | 3.2% | 1.1% |
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | 0.3% | 2.9% | 2.6% |
NIFTY500 MULTICAP INDIA MANUFACTURING 50:30:20 | 0.2% | 3.6% | 0.7% |
You may also like the below Video Courses
FAQ about DR REDDYS LABORATORIES Financials
How the annual revenues of DR REDDYS LABORATORIES have changed ?
The Revenues of DR REDDYS LABORATORIES have increased by 13.54% YoY .
How the Earnings per Share (EPS) of DR REDDYS LABORATORIES have changed?
The Earnings Per Share (EPS) of DR REDDYS LABORATORIES has decreased by -79.72 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs